BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12

• Press Releases

  HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics

  February 3, 2026

   · 

  3 min read
• Press Releases

  Slope and CellCarta Expand Collaboration with Lab Kit Inventory Portal Agreement

  February 3, 2026

   · 

  3 min read
• Press Releases

  AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Adults and Adolescents With Vitiligo

  February 3, 2026

   · 

  17 min read
• Press Releases

  Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer

  February 3, 2026

   · 

  6 min read
• Press Releases

  CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access

  February 3, 2026

   · 

  6 min read
• Press Releases

  Volta Medical’s RESTART Trial Shows Promising Findings for AI Solutions in Recurrent Atrial Fibrillation

  February 3, 2026

   · 

  5 min read
• Press Releases

  Rezurock® now reimbursed in Ontario and British Columbia for people living with chronic graft-versus-host disease (GVHD)

  February 3, 2026

   · 

  4 min read
• Press Releases

  ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy

  February 3, 2026

   · 

  3 min read
• Press Releases

  SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute

  February 3, 2026

   · 

  5 min read
• Press Releases

  CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026

  February 3, 2026

   · 

  4 min read